Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Sep;149(3):853–858.

MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

K Tóth 1, M M Vaughan 1, N S Peress 1, H K Slocum 1, Y M Rustum 1
PMCID: PMC1865160  PMID: 8780389

Abstract

The expression of human MDR1 P-glycoprotein (Pgp) in the capillary endothelial cells of the central nervous system has been demonstrated. The brain capillary endothelial cells maintain the structure and function of the blood-brain barrier. Recently, the human MDR1 Pgp (and its mouse homologue MDR1a Pgp) has been shown to function as an important part of this barrier, pumping out xenobiotics from endothelial cells into the lumen of capillaries resulting in the protection of the brain parenchyma. To examine whether the endothelial cells of the newly formed capillaries during neoangiogenesis within malignant human brain tumors express MDR1 Pgp, 35 adult surgical brain tumor specimens (29 gliomas and 6 tumors metastatic to the brain) were obtained from previously untreated patients and studied by a new immunohistochemical sandwich method developed in our laboratory using the JSB-1 monoclonal antibody. JSB-1 is specific for the Pgp product of the human MDR1 (and not MDR3) gene. This sensitive method allows the detection of Pgp in capillary endothelial cells of normal brain in conventional paraffin sections after formalin fixation. The endothelial cells of the newly formed capillaries in 25 of 29 gliomas (86%) and 3 of 6 metastatic tumors, immunostained positive for MDR1 Pgp. The tumor cells in 7 of 35 cases were also positive for Pgp. In the 35 brain tumor cases investigated, the endothelial cells were Pgp positive in the tumor-brain border and in the brain further from the tumor. Capillary endothelial cells of neovasculature in 137 malignant tumors (non-brain) obtained from previously untreated patients showed no MDR1 Pgp expression. These results demonstrated that MDR1 Pgp is expressed not only in the capillaries of normal brain but also in the majority of the newly formed capillaries of brain tumors. Multidrug resistance of brain tumors may result not only from the expression of resistance markers in neoplastic cells but also from the MDR1 Pgp expression in endothelial cells of tumor capillaries. Pgp in this special localization can exclude chemotherapeutic agents from tumor cells that are located around the capillaries. The therapeutic benefit and selectivity of chemotherapeutic agents in combination with a Pgp-reversing agent should be evaluated.

Full text

PDF
855

Images in this article

856Figure 1
on p.856

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker I., Becker K. F., Meyermann R., Höllt V. The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol. 1991;82(6):516–519. doi: 10.1007/BF00293387. [DOI] [PubMed] [Google Scholar]
  2. Cordon-Cardo C., O'Brien J. P., Boccia J., Casals D., Bertino J. R., Melamed M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem. 1990 Sep;38(9):1277–1287. doi: 10.1177/38.9.1974900. [DOI] [PubMed] [Google Scholar]
  3. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., Bertino J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A. 1989 Jan;86(2):695–698. doi: 10.1073/pnas.86.2.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FEEMSTER R. F., ANDERSON G. W. The control of typhoid carriers. Am J Public Health Nations Health. 1949 May;39(5 Pt 2):71–74. doi: 10.2105/ajph.39.5_pt_2.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Finstad C. L., Yin B. W., Gordon C. M., Federici M. G., Welt S., Lloyd K. O. Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis. J Histochem Cytochem. 1991 Dec;39(12):1603–1610. doi: 10.1177/39.12.1682363. [DOI] [PubMed] [Google Scholar]
  6. Hegmann E. J., Bauer H. C., Kerbel R. S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 1992 Dec 15;52(24):6969–6975. [PubMed] [Google Scholar]
  7. Henson J. W., Cordon-Cardo C., Posner J. B. P-glycoprotein expression in brain tumors. J Neurooncol. 1992 Sep;14(1):37–43. doi: 10.1007/BF00170943. [DOI] [PubMed] [Google Scholar]
  8. Matsumoto T., Tani E., Kaba K., Shindo H., Miyaji K. Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg. 1991 Mar;74(3):460–466. doi: 10.3171/jns.1991.74.3.0460. [DOI] [PubMed] [Google Scholar]
  9. Nabors M. W., Griffin C. A., Zehnbauer B. A., Hruban R. H., Phillips P. C., Grossman S. A., Brem H., Colvin O. M. Multidrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg. 1991 Dec;75(6):941–946. doi: 10.3171/jns.1991.75.6.0941. [DOI] [PubMed] [Google Scholar]
  10. Petrylak D. P., Scher H. I., Reuter V., O'Brien J. P., Cordon-Cardo C. P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder. Ann Oncol. 1994 Nov;5(9):835–840. doi: 10.1093/oxfordjournals.annonc.a059013. [DOI] [PubMed] [Google Scholar]
  11. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992 Oct 29;359(6398):845–848. doi: 10.1038/359845a0. [DOI] [PubMed] [Google Scholar]
  12. Schinkel A. H., Roelofs E. M., Borst P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 1991 May 15;51(10):2628–2635. [PubMed] [Google Scholar]
  13. Schinkel A. H., Smit J. J., van Tellingen O., Beijnen J. H., Wagenaar E., van Deemter L., Mol C. A., van der Valk M. A., Robanus-Maandag E. C., te Riele H. P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994 May 20;77(4):491–502. doi: 10.1016/0092-8674(94)90212-7. [DOI] [PubMed] [Google Scholar]
  14. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  15. Sikic B. I. Modulation of multidrug resistance: at the threshold. J Clin Oncol. 1993 Sep;11(9):1629–1635. doi: 10.1200/JCO.1993.11.9.1629. [DOI] [PubMed] [Google Scholar]
  16. Tanaka Y., Abe Y., Tsugu A., Takamiya Y., Akatsuka A., Tsuruo T., Yamazaki H., Ueyama Y., Sato O., Tamaoki N. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas. Virchows Arch. 1994;425(2):133–138. doi: 10.1007/BF00230349. [DOI] [PubMed] [Google Scholar]
  17. Tatsuta T., Naito M., Oh-hara T., Sugawara I., Tsuruo T. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem. 1992 Oct 5;267(28):20383–20391. [PubMed] [Google Scholar]
  18. Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem. 1989 Feb;37(2):159–164. doi: 10.1177/37.2.2463300. [DOI] [PubMed] [Google Scholar]
  19. Tóth K., Vaughan M. M., Slocum H. K., Arredondo M. A., Takita H., Baker R. M., Rustum Y. M. New immunohistochemical "sandwich" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am J Pathol. 1994 Feb;144(2):227–236. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES